189 related articles for article (PubMed ID: 11950621)
1. Oxygen radicals in cardiovascular-renal disease.
Schnackenberg CG
Curr Opin Pharmacol; 2002 Apr; 2(2):121-5. PubMed ID: 11950621
[TBL] [Abstract][Full Text] [Related]
2. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature.
Schnackenberg CG
Am J Physiol Regul Integr Comp Physiol; 2002 Feb; 282(2):R335-42. PubMed ID: 11792641
[TBL] [Abstract][Full Text] [Related]
3. A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes.
Jha JC; Ho F; Dan C; Jandeleit-Dahm K
Clin Sci (Lond); 2018 Aug; 132(16):1811-1836. PubMed ID: 30166499
[TBL] [Abstract][Full Text] [Related]
4. Renal oxidative stress, oxygenation, and hypertension.
Palm F; Nordquist L
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1229-41. PubMed ID: 21832206
[TBL] [Abstract][Full Text] [Related]
5. The endothelin system and endothelin receptor antagonists.
Jandeleit-Dahm KA; Watson AM
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):66-71. PubMed ID: 22123210
[TBL] [Abstract][Full Text] [Related]
6. Who's on first? Does hypertension in type I diabetics result from nephropathy or metabolic alterations?
Hinderliter AL; Runge MS
Circulation; 2001 Jul; 104(5):508-10. PubMed ID: 11479244
[No Abstract] [Full Text] [Related]
7. Research progress of sirtuins in renal and cardiovascular diseases.
Wang W; Li J; Cai L
Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):108-114. PubMed ID: 33229910
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
Montezano AC; Touyz RM
Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
[TBL] [Abstract][Full Text] [Related]
9. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus.
Haidara MA; Yassin HZ; Rateb M; Ammar H; Zorkani MA
Curr Vasc Pharmacol; 2006 Jul; 4(3):215-27. PubMed ID: 16842139
[TBL] [Abstract][Full Text] [Related]
10. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension.
Laragh J
Am J Hypertens; 2001 Apr; 14(4 Pt 1):307-10. PubMed ID: 11336175
[No Abstract] [Full Text] [Related]
11. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?
Giugliano D; Ceriello A; Paolisso G
Metabolism; 1995 Mar; 44(3):363-8. PubMed ID: 7885282
[TBL] [Abstract][Full Text] [Related]
12. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
Steckelings UM; Rompe F; Kaschina E; Unger T
Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.
Wilcox CS
Hypertension; 2012 Feb; 59(2):375-81. PubMed ID: 22215715
[TBL] [Abstract][Full Text] [Related]
14. Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus.
Biswas SK; Lopes de Faria JB
Am J Nephrol; 2006; 26(5):415-22. PubMed ID: 16960441
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?
Touyz RM
Hypertension; 2004 Sep; 44(3):248-52. PubMed ID: 15262903
[TBL] [Abstract][Full Text] [Related]
16. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
17. Update on calcium antagonists and the kidney.
Tobe S
Curr Opin Nephrol Hypertens; 2003 May; 12(3):309-15. PubMed ID: 12698071
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review).
Siti HN; Kamisah Y; Kamsiah J
Vascul Pharmacol; 2015 Aug; 71():40-56. PubMed ID: 25869516
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and cardiovascular health: therapeutic potential of polyphenols.
Khurana S; Piche M; Hollingsworth A; Venkataraman K; Tai TC
Can J Physiol Pharmacol; 2013 Mar; 91(3):198-212. PubMed ID: 23537433
[TBL] [Abstract][Full Text] [Related]
20. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
